WOCKPHARMA.BOWOCKPHARMA.BOBSE

Revenue (LTM)

$30.4B

+7.2% YoY

Net Income (LTM)

$-470M

+89.8% YoY

Free Cash Flow

$-2.6B

Revenue CAGR (5Y)

+1.3%

—Marginsstable

FCFTurned negative

Unprofitable

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Revenue	27,080	32,300↑19.3%	26,570↓17.7%	28,300↑6.5%	30,350↑7.2%
Gross Profit	14,980	18,810↑25.6%	14,850↓21.1%	15,980↑7.6%	18,260↑14.3%
Operating Income	5,330	9,871↑85.2%	7,060↓28.5%	8,362↑18.4%	10,536↑26.0%
Net Income	6,860	-2,440↓135.6%	-5,590↓129.1%	-4,630↑17.2%	-470↑89.8%
EBITDA	-1,430	2,260↑258.0%	420↓81.4%	1,380↑228.6%	3,600↑160.9%
EPS Diluted	-24.90	-20.24↑18.7%	-38.80↓91.7%	-32.10↑17.3%	-3.02↑90.6%

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Cash & Equivalents	2,323	3,700↑59.3%	900↓75.7%	5,050↑461.1%	1,910↓62.2%
Total Current Assets	24,244	25,890↑6.8%	22,080↓14.7%	21,840↓1.1%	24,650↑12.9%
Total Assets	77,727	82,430↑6.1%	76,830↓6.8%	76,490↓0.4%	81,350↑6.4%
Total Current Liabilities	31,182	32,070↑2.8%	34,350↑7.1%	27,910↓18.7%	20,420↓26.8%
Total Liabilities	40,124	40,410↑0.7%	40,210↓0.5%	39,870↓0.8%	34,780↓12.8%
Total Equity	33,768	38,490↑14.0%	33,540↓12.9%	33,590↑0.1%	43,530↑29.6%
Total Debt	26,730	21,980↓17.8%	21,840↓0.6%	23,560↑7.9%	20,210↓14.2%
Net Debt	24,407	18,280↓25.1%	20,940↑14.6%	18,510↓11.6%	18,300↓1.1%

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Operating Cash Flow	-2,873	4,130↑243.7%	1,530↓63.0%	2,190↑43.1%	-220↓110.0%
Capital Expenditure	-1,657	-2,120↓27.9%	-2,090↑1.4%	-2,160↓3.3%	-940↑56.5%
Free Cash Flow	-4,531	2,010↑144.4%	-560↓127.9%	30↑105.4%	-2,640↓8900.0%
Stock-Based Comp	20	10↓50.0%	10↓0.0%	10↓0.0%	0
Net Change in Cash	129	1,380↑968.9%	-2,800↓302.9%	4,150↑248.2%	-3,930↓194.7%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance